According to a new study, a high-voltage pulsed field ablation catheter effectively created transmural ventricular lesions, ...
Six-month outcomes from the Ventricular Catheter Ablation Study, the first-in-human evaluation of its FieldForce Ablation ...
Background: Unlike the tremendous progress made in atrial fibrillation ablation, the greatest unmet clinical need is for innovative ablation treatments for scar-related ventricular tachycardia (VT) – ...
An Abbott (NYSE: ABT) official posted on social media to announce FDA breakthrough device designation for a new ablation ...
Field Medical, Inc. today announced that Circulation has published six-month outcomes from the Ventricular Catheter Ablation ...
Radiation therapy may offer a comparable and potentially safer alternative to repeat catheter ablation for patients with ...
Medical Device Network on MSN
Adagio Medical reports findings from ventricular tachycardia study
Adagio Medical has reported preliminary acute efficacy and safety findings from its FULCRUM-VT Study, assessing the ULTC for ...
Key points A 68-year-old woman from rural Ontario arrived at her local emergency department with worsening palpitations. Her medical history included breast cancer treated with surgical resection and ...
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced preliminary ac ...
Findings presented at the International VT Symposium and published simultaneously in Circulation. CARDIFF-BY-THE-SEA, Calif.
SNS Insider projects the U.S. Electrophysiology Market to grow from USD 4.30 Billion in 2025E to USD 10.82 Billion by 2033, at a CAGR of 12.26%.Austin, Oct. 14, 2025 (GLOBE NEWSWIRE) -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback